159 related articles for article (PubMed ID: 4626080)
21. Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys.
Katchen B; Buxbaum S; Meyer J; Ning J
J Pharmacol Exp Ther; 1973 Feb; 184(2):453-64. PubMed ID: 4631713
[No Abstract] [Full Text] [Related]
22. Distribution, excretion metabolism and localization of a new anti-inflammatory drug: niflumic acid, labelled with 14C.
Glasson B; Benakis A; Strolin-Benedetti M
Biochem Pharmacol; 1969 Mar; 18(3):633-43. PubMed ID: 5772593
[No Abstract] [Full Text] [Related]
23. Disposition and metabolic fate of tiaramide hydrochloride, a new anti-inflammatory agent, in the rat.
Noguchi H; Okui M; Noda K; Kato R
Xenobiotica; 1977 Aug; 7(8):491-503. PubMed ID: 888450
[No Abstract] [Full Text] [Related]
24. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
Hayes A; Cooper RG
J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
[No Abstract] [Full Text] [Related]
25. [The pharmacokinetics and metabolism of a new choleretic, 3-ethyl-4-oxo-5-piperidino- 2, -thiazolidineacetic acid ethyl ester (Piprozolin) after enteral administration in the rat].
Vollmer KO; Koss FW
Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):312-32. PubMed ID: 5054739
[No Abstract] [Full Text] [Related]
26. Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse.
Goldaniga GC; Maraone C; Pianezzola E; Valzelli G; Ambrogi V
Arzneimittelforschung; 1973 Feb; 23(2):242-7. PubMed ID: 4739837
[No Abstract] [Full Text] [Related]
27. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
28. Terminal N-sulphoconjugation of an alicyclic amine (piperazine), identified as a new metabolite of tiaramide in mouse and rat.
Iwasaki K; Shiraga T; Noda K; Tada K; Noguchi H
Xenobiotica; 1983 May; 13(5):273-8. PubMed ID: 6636823
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man.
Vickers S; Stuart EK; Bianchine JR; Hucker HB; Jaffe ME; Rhodes RE; Vandenheuvel WJ
Drug Metab Dispos; 1974; 2(1):9-22. PubMed ID: 4150141
[No Abstract] [Full Text] [Related]
30. [Localisation, distribution, excretion and metabolism of the new, C 14 -labelled appetite depressant clobenzorex hydrochloride].
Glasson B; Benakis A; Thomasset M
Arzneimittelforschung; 1971 Dec; 21(12):1985-92. PubMed ID: 5171971
[No Abstract] [Full Text] [Related]
31. Metabolism of diazoxide in man and experimental animals.
Pruitt AW; Faraj BA; Dayton PG
J Pharmacol Exp Ther; 1974 Jan; 188(1):248-56. PubMed ID: 4203373
[No Abstract] [Full Text] [Related]
32. Localization and metabolism of drugs in the fetus.
Waddell WJ
Fed Proc; 1972; 31(1):52-61. PubMed ID: 4400374
[No Abstract] [Full Text] [Related]
33. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. 3. Species differences in metabolism.
Tanayama S
Xenobiotica; 1973 Oct; 3(10):671-80. PubMed ID: 4774633
[No Abstract] [Full Text] [Related]
34. Absorption, distribution, biotransformation, and excretion of azidocillin, a new semi-synthetic penicillin, in mice, rats and dogs.
Ramsay CH; Bodin NO; Hansson E
Arzneimittelforschung; 1972 Nov; 22(11):1962-70. PubMed ID: 4633590
[No Abstract] [Full Text] [Related]
35. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
Hucker HB; Grady LT; Michniewicz BM; Stauffer SC; White SE; Maha GE; McMahon FG
J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
[No Abstract] [Full Text] [Related]
37. Pharmacological actions of tiaramide hydrochloride: a new anti-inflammatory drug.
Tsurumi K; Hiramatsu Y; Nozaki M; Hayashi M; Fujimura H
Arzneimittelforschung; 1972 Apr; 22(4):724-32. PubMed ID: 5068254
[No Abstract] [Full Text] [Related]
38. Pharmacokinetic studies of mabuterol, a new selective beta 2-stimulant. I: Studies on the absorption, distribution and excretion in rats.
Yuge T; Hase T; Takayanagi Y; Kamasuka T; Amemiya K; Horiba M
Arzneimittelforschung; 1984; 34(11A):1659-67. PubMed ID: 6152159
[TBL] [Abstract][Full Text] [Related]
39. [Absorption, distribution, metabolism and excretion of 14C Etozolin in the rat, dog and man].
Vollmer KO; von Hodenberg A; Poisson A; Gladigau V; Hengy H
Arzneimittelforschung; 1977; 27(9a):1767-76. PubMed ID: 578766
[No Abstract] [Full Text] [Related]
40. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
